Krążek dopochwowy (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Krążek dopochwowy" in Polish language version.

refsWebsite
Global rank Polish rank
4th place
7th place
2nd place
6th place
1,169th place
2,752nd place
low place
low place
3,823rd place
low place
8,738th place
165th place
low place
8,813th place

chpl.com.pl

doi.org

  • D.R. Wieder, L. Pattimakiel. Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing). „Int J Womens Health”. 2, s. 401–409, 2010. DOI: 10.2147/IJWH.S6162. PMID: 21151688. 
  • K. Oddsson, B. Leifels-Fischer, N.R. de Melo, D. Wiel-Masson i inni. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. „Contraception”. 71 (3), s. 176–182, 2005. DOI: 10.1016/j.contraception.2004.09.001. PMID: 15722066. 
  • H.J. Ahrendt, I. Nisand, C. Bastianelli, M.A. Gómez i inni. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. „Contraception”. 74 (6), s. 451–457, 2006. DOI: 10.1016/j.contraception.2006.07.004. PMID: 17157101. 

medicines.org.uk

mp.pl

zakrzepica.mp.pl

nih.gov

ncbi.nlm.nih.gov

  • F.J. Roumen. Review of the combined contraceptive vaginal ring, NuvaRing. „Ther Clin Risk Manag”. 4 (2), s. 441–451, 2008. PMID: 18728840. 
  • D.R. Wieder, L. Pattimakiel. Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing). „Int J Womens Health”. 2, s. 401–409, 2010. DOI: 10.2147/IJWH.S6162. PMID: 21151688. 
  • T.M. Mulders, T.O. Dieben. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition. „Fertil Steril”. 75 (5), s. 865–870, 2001. PMID: 11334895. 
  • T.O. Dieben, F.J. Roumen, D. Apter. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. „Obstet Gynecol”. 100 (3), s. 585–593, 2002. PMID: 12220783. 
  • K. Oddsson, B. Leifels-Fischer, N.R. de Melo, D. Wiel-Masson i inni. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. „Contraception”. 71 (3), s. 176–182, 2005. DOI: 10.1016/j.contraception.2004.09.001. PMID: 15722066. 
  • H.J. Ahrendt, I. Nisand, C. Bastianelli, M.A. Gómez i inni. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. „Contraception”. 74 (6), s. 451–457, 2006. DOI: 10.1016/j.contraception.2006.07.004. PMID: 17157101. 

onkologia.org.pl

webmd.com